The Demo Floor will run 10+ grid-enabled applications on
hardware provided by HP and IBM . "This will be a venue where attendees
can interact with experts who have used grid computing and are
experiencing its quantifiable value.C., has been appointed to the Company's
Scientific Advisory Board.
A Senior Scientific Advisor for Schwarz Pharma AG, Dr. The
Company's research and pre-clinical CNS programs include Inosine for
the treatment of stroke and O-1369 for the treatment of Parkinson 's
disease.

short 1883

"Dr. (BLSI) is engaged in the research and
clinical development of diagnostic and therapeutic products for
central nervous system (CNS) disorders.

short memorial

"
"This is the first time a conference has presented so many actual
users talking about their experiences with grid," says Lionel Binns ,
Manager, Life Science Program Office, at HP, the conference Platinum
sponsor.D.A.

short 1950

Bianchine,
M.

page life

Business Editors/High-Tech Writers/Biotech Writers
2005 Life Sciences Grid Conference

AUSTIN, Texas + ZURICH, Switzerland----

Industry Leaders from Global Pharmaceutical Companies to Present
Papers on Grid Computing Across the Business

Zurich, Switzerland will play host to the 2005 Life Sciences Grid
Conference, an event focused on how grid computing is playing a
critical role and delivering proven business benefits in Life
Sciences.
Agenda highlights include presentations by Top Pharmas (Johnson +
Johnson, Novartis, GSK), leading Life Sciences software vendors
(Accelrys , Schrodinger, Tripos), analysts (Gartner, 451 Group) and
industry experts (HP, Institute for Systems Biology, Global Medical
Forum Foundation). Contact Mary Bass at 512-692-4118 for more
information . Bianchine strengthens our organization in two ways. Bianchine has authored over 300 scientific articles and book
chapters in the area of clinical pharmacology and founded the
Parkinson's Disease Research Institute at Texas Tech. from
State University of New York (Syracuse).

major thought

com/contact/registration. He received his
doctorate in Pharmacology at Albany Medical College and his M. I am looking forward to working with the Company's team of
highly regarded clinicians, researchers, and investigators ."

About Boston Life Sciences

Boston Life Sciences, Inc.

social 1883

2005 Life Sciences Grid Conference; First-Ever Results-Based Life Sciences Grid Conference to Take Place in Zurich Switzerland on February 21st and 22nd

background resume

Bianchine has been involved with the approval of 15 New Drug
Applications. The fundamental science which has been licensed from Harvard,
Children's Hospital of Boston and other collaborating institutions is
sound.

thought tradition

"Senior IT and Pharma executives, scientists and researchers with
major life science companies and related organizations could not ask
for a more focused conference to learn about strategies relevant to
their needs," said Manuel Peitsch, Global Head of Informatics +
Knowledge Management, Novartis. Second, his in-depth
knowledge in Parkinson's disease and stroke will benefit the clinical
development of ALTROPANE(R) and Inosine, as well as the pre-clinical
development of our Parkinson's therapeutic, O-1369," said Mark Pykett,
President and Chief Operating Officer of BLSI.D.

memorial publications

resume j

P. Bianchine brings extensive experience
in medicine and clinical pharmacology to BLSI .

science background

, F. Boston Life Sciences' actual
results could differ materially from those stated or implied in
forward-looking statements due to a number of factors, including those
factors contained in Boston Life Sciences' Annual Report on Form 10-K
filed with the Securities and Exchange Commission under the section
"Risk Factors," as well as other documents that may be filed by Boston
Life Sciences from time to time with the Securities and Exchange
Commission.
Boston Life Sciences assumes no obligations to update the information
in this press release.

life economics

thought background

With an unprecedented agenda of industry experts, the 2-day
Conference will provide attendees with an inside view of how grids are
being used and delivering value across the Pharma business."
Recognized reporters and analysts will be eligible to pre-register
for the full conference. Dr. Bianchine
is also currently a Fellow of the American College of Physicians and
the American College of Clinical Pharmacology , a Diplomat of the
American Board of Clinical Pharmacology and a member of the Editorial
Board for the Journal of Clinical Pharmacology, a position he has held
for the past 23 years. Bianchine 's experience spans both industry
and academia: he has held senior positions at Pharmacia + Upjohn ,
Farmitalia-Carlo Erba and Hoffman LaRoche, as well as faculty
positions at Ohio State University College of Medicine, Texas Tech
University (Lubbock) and Johns Hopkins University College of Medicine .

works schumpeter

Keynote Addresses: Manuel Peitsch, Novartis; David Neilson,
Johnson + Johnson

Speakers: GSK, Johnson + Johnson, Novartis, HP, Accelrys,
Schrodinger, Tripos, Gartner, The 451 Group, Global Medical Forum
Foundation, Institute for Systems Biology, Children's Memorial
Hospital, University of Basel

-- Who should attend: C-level Executives, IT Managers and End User of
Life Science Applications

-- When: February 21 - 22, 2005

-- Where: Zurich Marriott in Zurich, Switzerland

-- Why: To learn about grid computing from leading life
sciences users, ISV's, hardware vendors and
industry experts

-- How: To register or for more information, see:
https://www.

social publications

The registration fee will be waived by the
show organizers.ud.D.

page economics

, Ph.
"I am pleased to join the Scientific Advisory Board of Boston Life
Sciences," stated Dr.

life background

social major

As a long time supporter of grid
technology, HP is proud to be leading the field in support of this
conference.
Dr. BLSI's current research collaborations include Harvard
Medical School, Children's Hospital of Boston and the University of
Massachusetts-Worcester.

works short

htm .

-- Media: Executives will be available for interviews to
discuss key topics around Grid Computing for
Life Sciences

tradition intellectual

Boston Life Sciences Inc. Appoints Joseph R. Bianchine M.D. Ph.D. F.A.C.P. F.A.C.C.P. to Scientific Advisory Board

Business Editors/Medical Editors

BOSTON----Boston Life Sciences, Inc .

Statements in this press release regarding Boston Life Sciences'
future financial performance including statements regarding results of
operations and net loss, and any other statements about management's
future expectations, beliefs, goals, plans or prospects constitute
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding
Boston Life Sciences' expectations, beliefs, intentions or strategies
regarding the future and can be identified by forward-looking words
such as "anticipate ", "believe", "could", "estimate", "expect",
"intend", "may", "should", "will", and "would" or similar words.

life alois

Bianchine.

major sciences

Other highlights include a state-of-the-art Demo
Floor depicting an actual Pharma Grid, operating by business unit and
geography. "Finally the technology has matured to the point where
customers are able to speak from months, even years, of experience
about the value grid is delivering.
(NASDAQ: BLSI) (the "Company"), announced that Joseph R. Dr. ALTROPANE(R) is in Phase III
for the diagnosis of Parkinsonian Syndromes (PS) and Phase II for the
diagnosis of Attention Deficit Hyperactivity Disorder (ADHD).

publications works

A., F.C. "The Company's CNS product candidates
could address serious medical conditions that are presently poorly
met.

people resume

A former President of
the American Society of Clinical Pharmacology and Therapeutics, Dr. First, he
brings broad, complimentary clinical pharmacology and product
development skills to all of our programs.